Market revenue in 2023 | USD 237.3 million |
Market revenue in 2030 | USD 792.9 million |
Growth rate | 18.8% (CAGR from 2023 to 2030) |
Largest segment | Tavr (transcatheter aortic valve replacement) |
Fastest growing segment | LAAC (Left Atrial Appendage Closure) |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | SAVR (Surgical Aortic Valve Replacement), TAVR (Transcatheter Aortic Valve Replacement), Mitral Repair (Annuloplasty), LAAC (Left Atrial Appendage Closure) |
Key market players worldwide | Boston Scientific Corp, Medtronic PLC, Edwards Lifesciences Corp, Abbott Laboratories, St. Jude Medical, LivaNova PLC, Stryker Corp, Lepu Medical, Biomerics, CardioKinetix |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to structural heart devices market will help companies and investors design strategic landscapes.
Tavr (transcatheter aortic valve replacement) was the largest segment with a revenue share of 54.95% in 2023. Horizon Databook has segmented the South Korea structural heart devices market based on savr (surgical aortic valve replacement), tavr (transcatheter aortic valve replacement), mitral repair (annuloplasty), laac (left atrial appendage closure) covering the revenue growth of each sub-segment from 2018 to 2030.
South Korea's demographic landscape is evolving with a remarkable increase in life expectancy, attributed to advancements in healthcare, elevated living standards, and effective public health campaigns. This demographic shift has led to a surge in age-related cardiovascular conditions, notably aortic valve disorders, igniting a pressing demand for advanced cardiac interventions.
As the population ages, the prevalence of CVDs escalates, thereby fueling the need for cutting-edge CRM devices to address these health challenges. The aging populace places a substantial strain on South Korea's healthcare infrastructure, resulting in a heightened demand for medical devices and services.
This demographic transition, from 9 million seniors in 2022 to over 10 million in 2024, underscores the escalating healthcare requirements stemming from an aging society. Furthermore, heightened awareness among patients and healthcare practitioners regarding the advantages of minimally invasive procedures, such as TAVR, over traditional open-heart surgery is driving market expansion.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea structural heart devices market , including forecasts for subscribers. This country databook contains high-level insights into South Korea structural heart devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account